Galera Therapeutics CEO J Sorensen's 2022 pay falls 46% to $1.4M
Galera Therapeutics reports 2022 executive compensation
By ExecPay News
Published: April 27, 2023
Galera Therapeutics reported fiscal year 2022 executive compensation information on April 27, 2023.
In 2022, four executives at Galera Therapeutics received on average a compensation package of $936K, a 45% decrease compared to previous year.
Average pay of disclosed executives at Galera Therapeutics
J. Mel Sorensen, Chief Executive Officer, received $1.4M in total, which decreased by 46% compared to 2021. 44% of Sorensen's compensation, or $597K, was in salary. Sorensen also received $295K in non-equity incentive plan, $453K in option awards, as well as $16K in other compensation.
Christopher Degnan, Chief Financial Officer, received a compensation package of $835K, which decreased by 34% compared to previous year. 52% of the compensation package, or $432K, was in salary.
Mark Bachleda, Chief Commercial Officer, earned $789K in 2022, a 39% decrease compared to previous year.
Robert A. Beardsley, Chief Operating Officer, received $757K in 2022.
Related executives
You may also like
Source: SEC filing on April 27, 2023.